Related Experiment Videos
The neurobiologic consequences of Down syndrome
Brain Research Bulletin
|June 1, 1986
Summary
Down Syndrome (DS), caused by trisomy 21 (Ts21), leads to significant neurological abnormalities and brain structure changes. Research highlights the need to identify chromosome 21 genes and study animal models to understand these complex mechanisms.
Area of Science:
- Genetics
- Neuroscience
- Developmental Biology
Background:
- Down Syndrome (DS), resulting from trisomy of human chromosome 21 (HSA 21), is associated with intellectual disability and neurological deficits.
- Structural brain abnormalities in DS include reduced brain weight, altered cortical sulci, neuronal heterotopias, and decreased neuron populations.
Purpose of the Study:
- To investigate the underlying mechanisms of neurological abnormalities in Down Syndrome.
- To identify genes on HSA 21 contributing to DS phenotypes.
- To utilize animal models for studying DS pathogenesis.
Main Methods:
- Comparative analysis of brain structure in individuals with trisomy 21.
- Examination of cellular and dendritic abnormalities in key brain regions (hippocampus, cerebellum, cortex).
- Assessment of functional deficits in membrane properties and neurotransmitter systems.
Main Results:
- Observed structural changes include reduced brain weight and cortical abnormalities.
- Cellular abnormalities, particularly dendritic, are noted in various brain areas.
- Functional deficits in peripheral and central nervous systems are evident.
- Adult DS brains show neuropathological and neurochemical similarities to Alzheimer's disease (AD), with vulnerable cholinergic and noradrenergic systems.
Conclusions:
- Trisomy 21 causes significant structural and functional neurological abnormalities.
- DS brains exhibit features overlapping with Alzheimer's disease.
- Further research into HSA 21 genes and homologous animal models is crucial for understanding DS mechanisms.